Showing results (181-190 of 214) with videos related to
Sort By:
Pageof 22
Seminars in Oncology|April 6, 1999
Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor geneA H Calvert, S Ghokul, A Al-Azraqi, et al.Cancer Research|October 1, 1989
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine)I R Judson, A H Calvert, C J Rutty, et al.The Journal of Thoracic and Cardiovascular Surgery|October 2, 2007
Survival outcomes after rescue extracorporeal cardiopulmonary resuscitation in pediatric patients with refractory cardiac arrestBahaaldin Alsoufi, Osman O Al-Radi, Rakan I Nazer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
A phase I evaluation of the quinazoline antifolate thymidylate synthase inhibitor, N10-propargyl-5,8-dideazafolic acid, CB3717A H Calvert, D L Alison, S J Harland, et al.Journal of Medicinal Chemistry|October 1, 1985
Quinazoline antifolates inhibiting thymidylate synthase: variation of the N10 substituentT R Jones, A H Calvert, A L Jackman, et al.NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)A H Calvert, D R Newell, A L Jackman, et al.Journal of Medicinal Chemistry|March 17, 1995
Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl seriesP R Marsham, A L Jackman, A J Barker, et al.Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Resistance-modifying agents. Part 7: 2,6-disubstituted-4,8-dibenzylaminopyrimido[5,4-d]pyrimidines that inhibit nucleoside transport in the presence of alpha1-acid glycoprotein (AGP)H C Barlow, K J Bowman, N J Curtin, et al.Journal of Medicinal Chemistry|November 1, 1990
Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 positionL R Hughes, A L Jackman, J Oldfield, et al.British Journal of Cancer|June 1, 2001
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancerC A Maxwell-Armstrong, L G Durrant, T J Buckley, et al.Pageof 22